Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings, and welcome to the Bausch Health Second Quarter twenty twenty six Earnings Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. I'll now turn the conference over to Garen Saraffin, Vice President, Investor Relations. Thank you, Garen. You may begin. Good afternoon and welcome to Bausch Health's second quarter twenty twenty six earnings conference call. My name is Garen Saraffin, Vice President of Investor Relations. Participating in today's calls are Tom Appio, Chief Executive Officer JJ Charon, Chief Financial Officer and Jonathan Sadeh, Chief Medical Officer and Head of Research and Development. Before we begin, I would like to remind you that today's presentation contains forward looking information. Please take a moment to review the forward looking statements disclaimer at the beginning of the slides accompanying this presentation as it contains important information. Actual results may differ materially from those expressed or implied in these forward looking statements and you should not place undue reliance on them. Please also refer to our SEC filings and our filings with the Canadian Securities Administrators for a discussion of certain risk factors that could cause actual results to differ materially from expectations. We use non GAAP financial measures to help investors better understand our operating performance. These non GAAP measures may not be comparable to similarly titled measures used by other companies and should be considered in addition to and not as a substitute for measures calculated in accordance with GAAP. Reconciliations to our non GAAP measures are included in the appendix of the slides acc...